These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33539863)

  • 1. Tacrolimus Use and COVID-19 Infection in Patients After Solid Organ Transplantation.
    Yin S; Wang X; Song T
    Gastroenterology; 2021 Aug; 161(2):728-730.e1. PubMed ID: 33539863
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection.
    Joshi T; Rana A; Vierling JM; Kanwal F; Goss JA; Cholankeril G
    Liver Transpl; 2022 Jan; 28(1):127-130. PubMed ID: 34416083
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients.
    Salerno DM; Kovac D; Corbo H; Jennings DL; Lee J; Choe J; Scheffert J; Hedvat J; Chen J; Tsapepas D; Rosenblatt R; Samstein B; Halazun K; Verna E; Pereira M; Brennan C; Husain SA; Mohan S; Brown RS
    Clin Transplant; 2021 Mar; 35(3):e14193. PubMed ID: 33336440
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir.
    Gonzalez-García R; Roma JR; Rodríguez-García M; Arranz N; Ambrosioni J; Bodro M; Castel MÁ; Cofan F; Crespo G; Diekmann F; Farrero M; Forner A; LLigoña A; Marcos MÁ; Moreno A; Ruiz P; Soy D; Brunet M; Miró JM; Tuset M
    Clin Microbiol Infect; 2023 May; 29(5):655.e1-655.e4. PubMed ID: 36641051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19.
    Pearson MM; Limaye AP; Biggins SW
    Gastroenterology; 2021 Mar; 160(4):1012-1013. PubMed ID: 33387518
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical insights into the role of immunosuppression in solid organ transplant recipients with COVID-19.
    Kolonko A; Kuczaj AA; Musialik J; Słabiak-Błaż N; Hrapkowicz T; Przybyłowski P; Więcek A
    Pol Arch Intern Med; 2022 Nov; 132(2):. PubMed ID: 34779600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients.
    Wang J; Guo R; Liu S; Chen Q; Zuo S; Yang M; Zuo X
    Chin Med J (Engl); 2014; 127(20):3645-50. PubMed ID: 25316243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation Population.
    Brigham MD; Milgroom A; Lenco MO; Wang Z; Kent JD; LaMoreaux B; Johnson RJ; Mandell BF; Hadker N; Sanchez H; Francis K; Radeck LP; Miyasato G; Li JW
    Prog Transplant; 2020 Jun; 30(2):103-110. PubMed ID: 32208882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis.
    Karruli A; Spiezia S; Boccia F; Gagliardi M; Patauner F; Salemme A; Maiello C; Zampino R; Durante-Mangoni E
    Transpl Infect Dis; 2021 Aug; 23(4):e13595. PubMed ID: 33641202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic.
    Souaid K; Klejtman T; Kramkimel N; Isnard C; Dupin N; Aractingi S
    Ann Dermatol Venereol; 2021 Jun; 148(2):122-123. PubMed ID: 33551212
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with sirolimus ameliorates tacrolimus-induced autoimmune cytopenias after solid organ transplant.
    Teachey DT; Jubelirer T; Baluarte HJ; Wade A; Manno CS
    Pediatr Blood Cancer; 2009 Dec; 53(6):1114-6. PubMed ID: 19621445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use.
    Ng AC
    Hepatol Commun; 2021 Oct; 5(10):1801-1802. PubMed ID: 34222740
    [No Abstract]   [Full Text] [Related]  

  • 13. Catatonia as a manifestation of tacrolimus-induced neurotoxicity in organ transplant patients: a case series.
    Chopra A; Das P; Rai A; Kuppuswamy PS; Li X; Huston J; Philbrick K; Sola C
    Gen Hosp Psychiatry; 2012; 34(2):209.e9-11. PubMed ID: 21937118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food allergy after pediatric organ transplantation with tacrolimus immunosuppression.
    Nowak-Wegrzyn AH; Sicherer SH; Conover-Walker MK; Wood RA
    J Allergy Clin Immunol; 2001 Jul; 108(1):146-7. PubMed ID: 11447402
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.
    Qin CX; Moore LW; Anjan S; Rahamimov R; Sifri CD; Ali NM; Morales MK; Tsapepas DS; Basic-Jukic N; Miller RA; van Duin D; Santella RN; Wadei HM; Shah PD; Gage N; Malinis M; Aslam S; Todesco E; Werbel WA; Avery RK; Segev DL
    Transplantation; 2021 Nov; 105(11):e265-e266. PubMed ID: 34310531
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is it possible to prevent kidney problems caused by immunosuppression?].
    Aitio ML
    Duodecim; 2000; 116(5):511-9. PubMed ID: 11787104
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of immunosuppressive regimes on posttransplant diabetes mellitus.
    Weir M
    Transplant Proc; 2001 Aug; 33(5A Suppl):23S-26S. PubMed ID: 11498201
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?
    NasrAllah MM; Osman NA; Elalfy M; Malvezzi P; Rostaing L
    Rev Med Virol; 2021 Jan; 31(1):1-9. PubMed ID: 32954602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients.
    Zilla ML; Keetch C; Mitchell G; McBreen J; Shurin MR; Wheeler SE
    J Appl Lab Med; 2021 Mar; 6(2):486-490. PubMed ID: 33367709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination.
    Wadei HM; Gonwa TA; Leoni JC; Shah SZ; Aslam N; Speicher LL
    Am J Transplant; 2021 Oct; 21(10):3496-3499. PubMed ID: 33890410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.